Skip to main content
Identifying Gaps and Disparities in Screening for Cystic Fibrosis Associated Liver Disease: Insights From a CF Center Analysis.
A Joint Conversation: People With Cystic Fibrosis' Perception of Healthcare Teams' Knowledge, Comfort, and Barriers in Discussing Substance Use.
Prostaglandin E1 in neonatal pulmonary hypertension: Need for randomized trials based on physiology-Response.
Improved detection of cystic fibrosis by the California Newborn Screening Program for all races and ethnicities.
Opportunities for trauma-informed medical care in cystic fibrosis.
Time to be blunt: Substance use in cystic fibrosis.
Cystic fibrosis transmembrane conductance regulator modulator administration to a F508del heterozygous infant with meconium pseudocyst and short bowel syndrome: A case report.
Prostaglandin-E1 infusion in persistent pulmonary hypertension of the newborn.
How Many Billions Is Enough? Prioritizing Profits Over Patients With Cystic Fibrosis.
Sociodemographic factors associated with tracheostomy and mortality in bronchopulmonary dysplasia.